menu
    • menu

    Company profile for Fujifilm Toyama Chemical

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Fujifilm Ri Pharma Co.,Ltd. was founded in 2006. The Company's line of business includes the manufacturing, fabricating, or processing of drugs in pharmaceutical preparations for human or veterinary use. Fujifilm Toyama Chemical Co Ltd is located in Nagoya, Aichi, Japan and is part of the Pharmaceutical Manufacturing Industry. There are 1,114 companies in the Fujifilm Toyama Chemical Co Ltd. corporate family.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Fujifilm Toyama Chemicaljapan Flag
    Country
    Country
    Japan
    Address
    Address
    1-17-10 Kyobashi Chuo-ku Tokyo, 104-0031 Japan
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.fujifilm.com/fftc/en
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Grants FF-10832 Orphan Drug Status for Biliary Tract Cancer
    FDA Grants FF-10832 Orphan Drug Status for Biliary Tract Cancer

    07 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250707338743/en/FF-10832-Granted-FDA-Orphan-Drug-Designation-for-the-Treatment-of-Biliary-Tract-Cancer

    BUSINESSWIRE
    07 Jul 2025
    Share Share
    Fujifilm terminates P III enrollment for Avigan drug trial in Japan
    Fujifilm terminates P III enrollment for Avigan drug trial in Japan

    15 Mar 2022

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/25/19862/fujifilm-terminates-ph-iii-enrolment-for-avigan-drug-trial-in-japan-due-to-omicron-variant.html

    BIOSPECTRUMASIA
    15 Mar 2022
    Share Share
    Japan's Fujifilm sells radiopharma biz to PeptiDream for 30.5 billion yen
    Japan's Fujifilm sells radiopharma biz to PeptiDream for 30.5 billion yen

    03 Sep 2021

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/27/18964/japans-fujifilm-sells-radiopharma-biz-to-peptidream-for-30-5-billion-yen.html

    BIOSPECTRUM ASIA
    03 Sep 2021
    Share Share
    Fujifilm initiates new Ph III trial of Avigan for COVID-19 treatment in Japan
    Fujifilm initiates new Ph III trial of Avigan for COVID-19 treatment in Japan

    20 Apr 2021

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/96/18030/fujifilm-initiates-new-ph-iii-trial-of-avigan-for-covid-19-treatment-in-japan.html

    BIOSPECTRUMASIA
    20 Apr 2021
    Share Share
    Genentech Sues Centus Over Proposed Bevacizumab Biosimilar
    Genentech Sues Centus Over Proposed Bevacizumab Biosimilar

    16 Nov 2020

    // BIGMOLECULEWATCH

    https://www.bigmoleculewatch.com/2020/11/13/genentech-sues-centus-over-proposed-bevacizumab-biosimilar/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+GoodwinProcter-BigMoleculeWatchBlog+%28Big+Molecule+Watch+Blog+%7C+Goodwin%29

    BIGMOLECULEWATCH
    16 Nov 2020
    Share Share
    Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan
    Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan

    19 Oct 2020

    // Chris Gallagher REUTERS

    https://www.reuters.com/article/us-health-coronavirus-fujifilm-avigan/fujifilm-seeks-approval-for-avigan-as-covid-19-treatment-in-japan-idUSKBN27109Z

    Chris Gallagher REUTERS
    19 Oct 2020
    Share Share

    ABOUT THIS PAGE

    Contact Fujifilm Toyama Chemical and get a quotation

    Fujifilm Toyama Chemical is a supplier offers 8 products (APIs, Excipients or Intermediates).

    Find Borax Solution bulk with JDMF offered by Fujifilm Toyama Chemical

    Find Boric Acid bulk with JDMF offered by Fujifilm Toyama Chemical

    Find Ciprofloxacin bulk with JDMF offered by Fujifilm Toyama Chemical

    Find Piperacillin Sodium bulk with JDMF offered by Fujifilm Toyama Chemical

    Find Garenoxacin bulk offered by Fujifilm Toyama Chemical

    Find T-588 DRUG SUBSTANCE bulk offered by Fujifilm Toyama Chemical

    Find Pazufloxacin Mesylate bulk offered by Fujifilm Toyama Chemical

    Find Tosuxacin bulk offered by Fujifilm Toyama Chemical

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search